期刊簡(jiǎn)介預(yù)計(jì)審稿時(shí)間： 一般,3-8周

Diabetes, Obesity and Metabolism is primarily a journal of clinical and experimental pharmacology and therapeutics covering the interrelated areas of diabetes, obesity and metabolism. The journal prioritises high-quality original research that reports on the effects of new or existing therapies, including dietary, exercise and lifestyle (non-pharmacological) interventions, in any aspect of metabolic and endocrine disease, either in humans or animal and cellular systems. ‘Metabolism’ may relate to lipids, bone and drug metabolism, or broader aspects of endocrine dysfunction. Preclinical pharmacology, pharmacokinetic studies, meta-analyses and those addressing drug safety and tolerability are also highly suitable for publication in this journal. Original research may be published as a main paper or as a research letter.

《糖尿病、肥胖和代謝》主要刊登臨床和實(shí)驗(yàn)藥理學(xué)和治療學(xué)雜志，涵蓋糖尿病、肥胖和代謝相關(guān)領(lǐng)域。該雜志優(yōu)先刊登高質(zhì)量的原創(chuàng)研究，報(bào)告新療法或現(xiàn)有療法（包括飲食、運(yùn)動(dòng)和生活方式（非藥物）干預(yù)）對(duì)人類或動(dòng)物和細(xì)胞系統(tǒng)代謝和內(nèi)分泌疾病任何方面的影響?！按x”可能與脂質(zhì)、骨骼和藥物代謝或內(nèi)分泌功能障礙的更廣泛方面有關(guān)。臨床前藥理學(xué)、藥代動(dòng)力學(xué)研究、薈萃分析以及涉及藥物安全性和耐受性的研究也非常適合在該雜志上發(fā)表。原創(chuàng)研究可以作為主要論文或研究信函發(fā)表。

《Diabetes Obesity & Metabolism》(糖尿病肥胖與代謝)編輯部通訊方式為WILEY-BLACKWELL PUBLISHING, INC, COMMERCE PLACE, 350 MAIN ST, MALDEN, USA, MA, 02148。如果您需要協(xié)助投稿或潤稿服務(wù)，您可以咨詢我們的客服老師。我們專注于期刊咨詢服務(wù)十年，熟悉發(fā)表政策，可為您提供一對(duì)一投稿指導(dǎo)，避免您在投稿時(shí)頻繁碰壁，節(jié)省您的寶貴時(shí)間，有效提升發(fā)表機(jī)率，確保SCI檢索（檢索不了全額退款）。我們視信譽(yù)為生命，多方面確保文章安全保密，在任何情況下都不會(huì)泄露您的個(gè)人信息或稿件內(nèi)容。